|
|
- CAS號:
- 2101626-26-8
- 英文名:
- GSK2894631A
- 英文別名:
- GSK2894631A;HPGDS inhibitor 2;GSK-2894631A(HPGDS inhibitor 2);HPGDS inhibitor 2, 10 mM in DMSO;7-(Difluoromethoxy)-N-(trans-4-(2-hydroxypropan-2-yl)cyclohexyl)quinoline-3-carboxamide;7-(difluoromethoxy)-N-[(1r,4r)-4-(2-hydroxypropan-2-yl)cyclohexyl]quinoline-3-carboxamide;7-(Difluoromethoxy)- N-[trans-4-(1-hydroxy-1-methylethyl)cyclohexyl]-3-quinolinecarboxamide;3-Quinolinecarboxamide, 7-(difluoromethoxy)-N-[trans-4-(1-hydroxy-1-methylethyl)cyclohexyl]-;HPGDS inhibitor2,PGE synthase,Inhibitor,inhibit,HPGDS inhibitor-2,HPGDS inhibitor 2,Prostaglandin E synthase
- 中文名:
- GSK-2894631A
- 中文別名:
- 化合物GSK-2894631A;化合物GSK-2894631A,10 MM DMSO 溶液;7-(二氟甲氧基)-N-(TRANS-4-(2-羥丙基-2-環(huán)己基)喹啉-3-甲酰胺;7-(二氟甲氧基)-N-[反式-4-(1-羥基-1-甲基乙基)環(huán)己基]-3-喹啉甲酰胺
- CBNumber:
- CB44882154
- 分子式:
- C20H24F2N2O3
- 分子量:
- 378.41
- MOL File:
- 2101626-26-8.mol
|
|
|